Plaintiff's counsel announced today that a personal injury lawsuit against Baxter Healthcare for a near fatal adverse reaction from its contaminated prescription drug Heparin was filed in federal court in New Jersey, where Baxter Healthcare, a division of Baxter International, manufactured and marketed Heparin. The claimant seeks damages for physical pain and medical expenses, as well as punitive damages to deter Baxter from similar wrongdoing in the future.
CAMDEN, N.J. (Business Wire EON) April 3, 2008 --
Plaintiff’s counsel announced today that a
personal injury lawsuit against Baxter Healthcare for a near fatal
adverse reaction from its contaminated prescription drug Heparin was
filed in federal court in New Jersey, where Baxter Healthcare, a
division of Baxter International, manufactured and marketed Heparin. The
claimant seeks damages for physical pain and medical expenses, as well
as punitive damages to deter Baxter from similar wrongdoing in the
future.
The FDA has reported that over a score of deaths and hundreds of severe
allergic reactions have been linked to contaminated Heparin. On March
19, 2008, the FDA announced that the active ingredient in Heparin sold
by Baxter was contaminated at the Chinese manufacturing facilities, with
a chemically altered form of chondroitin sulfate, a dietary supplement
made from animal cartilage that is widely used to treat joint pain.
“Prescription drug manufacturers have a duty
to produce products that are safe and free of dangerous ingredients,”
stated Wendy R. Fleishman of the New York City office of the national
plaintiffs’ law firm Lieff Cabraser Heimann &
Bernstein, LLP. “Only through a lawsuit or
otherwise making a claim against Baxter can patients obtain compensation
for their injuries. The American public needs the drug companies, like
Baxter, to take responsibility for the safety of their products --
especially those like Heparin, which are manufactured in part in China.”
“The complaint charges Baxter with selling
Heparin that was defective due to contamination and inadequately
inspecting its product,” noted Seth R. Lesser
of the Locks Law Firm, PLLC, and co-plaintiff’s
counsel. “Baxter failed to undertake adequate
testing that would have shown that its Heparin posed a life-threatening
risk to patients.”
Information for Heparin Patients
The law in most states provides several personal injury claims for
persons who have been seriously injured due to defective prescription
drugs and treatments. These claims include strict liability for a
defective product, failure to warn, and negligence.
If you would like to learn more about the Heparin recall and your legal
rights, please visit http://www.personalinjurylawyeramerica.com/medical/heparin.htm.
Injured patients and the families of loved ones who died are also
welcome to call plaintiffs’ counsel toll-free
at 1-800-541-7358 and ask to speak to attorney Heather A. Foster of
Lieff Cabraser.
Resources for Reporters
Reporters who wish to receive a copy of the complaint are welcome to
contact Brandan de Coteau of Lieff Cabraser at bdecoteau@lchb.com
or (415) 956-1000.
About Plaintiff’s
Counsel
Lieff Cabraser Heimann & Bernstein, LLP is a fifty-plus attorney law
firm that has represented plaintiffs nationwide since 1972. The firm has
offices in New York, San Francisco and Nashville. Lieff Cabraser
represents plaintiffs in class and group actions and in individual
lawsuits in cases involving substantial losses. For the last five years,
the National Law Journal has selected Lieff Cabraser as one of
the top plaintiffs' law firms in the nation. Learn more at www.lieffcabraser.com
With 26 lawyers and a staff of over one hundred in its New York,
Philadelphia, and New Jersey offices, Locks Law Firm, PLLC is committed
to obtaining justice for its clients and achieving a safer society by
seeking jury verdicts that take the profit out of the manufacture of
defective products and careless conduct. The firm has more than four
decades of experience in litigation involving numerous types of personal
injury and class action and consumer fraud claims. Learn more at www.lockslaw.com
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1TdW1tLUhvcnItWmV0YS1TdW1tLVplcm8=
|
